Hillevax Quarterly Balance Sheets Chart
Quarterly
|
Annual
Hillevax Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||
| current assets: | ||||||||||||||
| cash and cash equivalents | 58,677,000 | 47,485,000 | 154,467,000 | 103,764,000 | 108,444,000 | 141,076,000 | 216,678,000 | 208,502,000 | 158,375,000 | 260,542,000 | 279,401,000 | 292,060,000 | 314,612,000 | 111,252,000 |
| marketable securities | 100,870,000 | 112,054,000 | 16,965,000 | 85,546,000 | 136,596,000 | 131,667,000 | 86,805,000 | 115,908,000 | 85,675,000 | |||||
| prepaid expenses and other current assets | 2,229,000 | 5,577,000 | 6,915,000 | 7,860,000 | 7,486,000 | 8,355,000 | 7,195,000 | 8,785,000 | 8,989,000 | 9,317,000 | 11,212,000 | 8,094,000 | 4,893,000 | 480,000 |
| assets held for sale | 465,000 | 593,000 | ||||||||||||
| total current assets | 162,241,000 | 165,709,000 | 178,347,000 | 197,170,000 | 252,526,000 | 281,098,000 | 310,678,000 | 333,195,000 | 253,039,000 | 269,859,000 | 290,613,000 | 300,154,000 | 319,505,000 | 111,732,000 |
| property and equipment | 4,026,000 | 4,231,000 | 5,222,000 | 9,775,000 | 10,363,000 | 13,592,000 | 14,018,000 | 13,744,000 | 13,143,000 | 10,450,000 | 5,586,000 | 600,000 | ||
| operating lease right-of-use assets | 6,990,000 | 7,227,000 | 7,467,000 | 12,022,000 | 12,388,000 | 17,831,000 | 18,082,000 | 18,377,000 | 18,686,000 | 18,999,000 | 19,359,000 | 19,670,000 | 20,075,000 | 176,000 |
| restricted cash | 1,631,000 | 1,631,000 | 1,631,000 | 1,631,000 | 1,631,000 | 1,631,000 | 1,631,000 | 1,631,000 | 1,631,000 | 1,631,000 | 1,631,000 | 1,631,000 | 1,631,000 | |
| other assets | 26,000 | 23,000 | 23,000 | 24,000 | 23,000 | 23,000 | 25,000 | 22,000 | 23,000 | 22,000 | 22,000 | 21,000 | 21,000 | 2,788,000 |
| total assets | 174,914,000 | 178,821,000 | 192,690,000 | 220,622,000 | 276,931,000 | 314,175,000 | 344,434,000 | 366,969,000 | 286,522,000 | 300,961,000 | 317,211,000 | 322,076,000 | 341,232,000 | 114,696,000 |
| liabilities and stockholders’ equity | ||||||||||||||
| current liabilities: | ||||||||||||||
| accounts payable | 113,000 | 72,000 | 3,237,000 | 1,208,000 | 3,850,000 | 2,980,000 | 7,461,000 | 3,287,000 | 151,000 | 1,744,000 | 4,744,000 | 875,000 | 6,033,000 | 4,010,000 |
| accrued expenses | 2,404,000 | 2,874,000 | 9,648,000 | 9,082,000 | 16,003,000 | 19,143,000 | 18,553,000 | 12,889,000 | 17,648,000 | 17,412,000 | 8,210,000 | 7,699,000 | 6,419,000 | 4,778,000 |
| current portion of operating lease liability | 3,630,000 | 3,599,000 | 3,570,000 | 3,546,000 | 3,516,000 | 3,491,000 | 3,118,000 | 2,654,000 | 437,000 | 38,000 | 37,000 | 34,000 | 35,000 | 35,000 |
| total current liabilities | 6,147,000 | 6,545,000 | 16,455,000 | 13,836,000 | 49,165,000 | 25,749,000 | 29,266,000 | 18,958,000 | 18,338,000 | 19,273,000 | 13,046,000 | 8,633,000 | 12,510,000 | 282,926,000 |
| operating lease liability, net of current portion | 19,912,000 | 20,440,000 | 20,943,000 | 21,427,000 | 21,896,000 | 22,364,000 | 22,831,000 | 23,247,000 | 23,664,000 | 22,977,000 | 21,569,000 | 21,134,000 | 20,790,000 | 141,000 |
| other long-term liabilities | 1,036,000 | 923,000 | 806,000 | 1,086,000 | 940,000 | 1,700,000 | 1,568,000 | 1,096,000 | 922,000 | 747,000 | 575,000 | 379,000 | 81,000 | 1,000 |
| total liabilities | 27,095,000 | 27,908,000 | 38,204,000 | 36,349,000 | 72,001,000 | 75,266,000 | 78,909,000 | 68,339,000 | 67,759,000 | 57,900,000 | 49,982,000 | 34,883,000 | 38,078,000 | 283,068,000 |
| commitments and contingencies | ||||||||||||||
| stockholders’ equity: | ||||||||||||||
| preferred stock, 0.0001 par value; authorized shares— 50,000,000 at june 30, 2025 and december 31, 2024; no shares issued and outstanding at june 30, 2025 and december 31, 2024 | ||||||||||||||
| common stock | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 4,000 | 4,000 | 4,000 | 3,000 | 3,000 | 1,000 |
| additional paid-in capital | 696,206,000 | 693,876,000 | 691,447,000 | 686,968,000 | 681,918,000 | 675,242,000 | 654,986,000 | 650,567,000 | 538,865,000 | 535,221,000 | 532,499,000 | 530,995,000 | 530,151,000 | 4,698,000 |
| accumulated other comprehensive loss | -1,239,000 | -1,081,000 | -1,140,000 | -821,000 | -937,000 | -950,000 | -907,000 | -343,000 | -322,000 | -282,000 | -281,000 | |||
| accumulated deficit | -547,153,000 | -541,887,000 | -535,826,000 | -501,879,000 | -476,056,000 | -435,388,000 | -388,559,000 | -351,599,000 | -319,784,000 | -291,882,000 | -264,993,000 | -243,805,000 | -227,000,000 | -173,071,000 |
| total stockholders’ equity | 147,819,000 | 150,913,000 | 154,486,000 | 184,273,000 | 204,930,000 | 238,909,000 | 265,525,000 | 298,630,000 | 218,763,000 | 243,061,000 | 267,229,000 | 287,193,000 | 303,154,000 | |
| total liabilities and stockholders’ equity | 174,914,000 | 178,821,000 | 192,690,000 | 220,622,000 | 276,931,000 | 314,175,000 | 344,434,000 | 366,969,000 | 286,522,000 | 300,961,000 | 317,211,000 | 322,076,000 | 341,232,000 | |
| preferred stock, 0.0001 par value; authorized shares— 50,000,000 at march 31, 2025 and december 31, 2024; no shares issued and outstanding at march 31, 2025 and december 31, 2024 | ||||||||||||||
| accrued interest | 131,000 | 135,000 | 134,000 | 128,000 | 102,000 | 79,000 | 55,000 | 25,000 | 23,000 | 4,885,000 | ||||
| long-term debt, net of debt discount | 25,453,000 | 25,244,000 | 25,038,000 | 24,835,000 | 14,903,000 | 14,792,000 | 4,737,000 | 4,697,000 | ||||||
| preferred stock, 0.0001 par value; authorized shares— 50,000,000 at december 31, 2024 and december 31, 2023; no shares issued and outstanding at december 31, 2024 and december 31, 2023 | ||||||||||||||
| preferred stock, 0.0001 par value; authorized shares— 50,000,000 at september 30, 2024 and december 31, 2023; no shares issued and outstanding at september 30, 2024 and december 31, 2023 | ||||||||||||||
| current portion of long-term debt, net of debt discount | 25,665,000 | |||||||||||||
| preferred stock, 0.0001 par value; authorized shares— 50,000,000 at june 30, 2024 and december 31, 2023; no shares issued and outstanding at june 30, 2024 and december 31, 2023 | ||||||||||||||
| preferred stock, 0.0001 par value; authorized shares— 50,000,000 at march 31, 2024 and december 31, 2023; no shares issued and outstanding at march 31, 2024 and december 31, 2023 | ||||||||||||||
| preferred stock, 0.0001 par value; authorized shares— 50,000,000 at december 31, 2023 and december 31, 2022; no shares issued and outstanding at december 31, 2023 and december 31, 2022 | ||||||||||||||
| preferred stock, 0.0001 par value; authorized shares— 50,000,000 at september 30, 2023 and december 31, 2022; no shares issued and outstanding at september 30, 2023 and december 31, 2022 | ||||||||||||||
| preferred stock, 0.0001 par value; authorized shares— 50,000,000 at june 30, 2023 and december 31, 2022; no shares issued and outstanding at june 30, 2023 and december 31, 2022 | ||||||||||||||
| preferred stock, 0.0001 par value; authorized shares— 50,000,000 at march 31, 2023 and december 31, 2022; no shares issued and outstanding at march 31, 2023 and december 31, 2022 | ||||||||||||||
| convertible promissory notes payable at fair value | 175,349,000 | |||||||||||||
| warrant liabilities - related party | 93,869,000 | |||||||||||||
| stockholders’ equity | ||||||||||||||
| preferred stock, 0.0001 par value; authorized shares— 50,000,000 and 0 at december 31, 2022 and december 31, 2021, respectively; no shares issued and outstanding at december 31, 2022 and december 31, 2021 | ||||||||||||||
| preferred stock, 0.0001 par value; authorized shares— 50,000,000 and 0 at september 30, 2022 and december 31, 2021, respectively; no shares issued and outstanding at september 30, 2022 and december 31, 2021 | ||||||||||||||
| preferred stock, 0.0001 par value; authorized shares— 50,000,000 and 0 at june 30, 2022 and december 31, 2021, respectively; no shares issued and outstanding at june 30, 2022 and december 31, 2021 | ||||||||||||||
| liabilities and stockholders’ deficit | ||||||||||||||
| stockholders’ deficit: | ||||||||||||||
| total stockholders’ deficit | -168,372,000 | |||||||||||||
| total liabilities and stockholders’ deficit | 114,696,000 |
We provide you with 20 years of balance sheets for Hillevax stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Hillevax. Explore the full financial landscape of Hillevax stock with our expertly curated balance sheets.
The information provided in this report about Hillevax stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.